Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
expedited its development after the company closed Series B financing in September 2021. It recently acquired Ann Arbor Pharmacometrics Group
expedited its development after the company closed Series B financing in September 2021. It recently acquired Ann Arbor Pharmacometrics Group